| RS879255568 |
ARL2BP
|
Health Risk |
Pathogenic |
Retinitis pigmentosa with or without situs inversus, Retinitis pigmentosa |
| RS879255569 |
BCAP31
|
Health Risk |
Pathogenic |
Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome, Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome |
| RS879255570 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS879255571 |
CTCF
|
Health Risk |
Pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS879255572 |
ARL6IP1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 61, Hereditary spastic paraplegia 61 |
| RS879255573 |
GRHL3
|
Health Risk |
Pathogenic |
Van der Woude syndrome 2, Van der Woude syndrome 2 |
| RS879255574 |
ASPH
|
Health Risk |
Pathogenic |
Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome, Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome |
| RS879255575 |
CEP83
|
Health Risk |
Pathogenic |
Nephronophthisis 18, Nephronophthisis 18 |
| RS879255576 |
CEP83
|
Health Risk |
Pathogenic |
Nephronophthisis 18, Nephronophthisis 18 |
| RS879255578 |
CAV1
|
Health Risk |
Pathogenic |
Partial lipodystrophy, congenital cataracts |
| RS879255579 |
ALDH6A1
|
Health Risk |
Pathogenic |
Methylmalonate semialdehyde dehydrogenase deficiency, Methylmalonate semialdehyde dehydrogenase deficiency |
| RS879255580 |
CLCN4
|
Health Risk |
Pathogenic |
CLCN4-related disorder, CLCN4-related disorder |
| RS879255581 |
CLCN4
|
Health Risk |
Pathogenic |
CLCN4-related disorder, CLCN4-related disorder |
| RS879255582 |
CLCN4
|
Health Risk |
Pathogenic |
CLCN4-related disorder, CLCN4-related disorder |
| RS879255583 |
CLCN4
|
Health Risk |
Pathogenic |
CLCN4-related disorder, Inborn genetic diseases |
| RS879255584 |
CLCN4
|
Health Risk |
Pathogenic |
CLCN4-related disorder, Intellectual disability |
| RS879255585 |
CLCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
CLCN4-related disorder, Intellectual disability |
| RS879255586 |
CLCN4
|
Health Risk |
Pathogenic |
CLCN4-related disorder, CLCN4-related disorder |
| RS879255587 |
PTCHD1
|
Health Risk |
risk factor |
Autism, susceptibility to |
| RS879255589 |
TRU-TCA1-1
|
Health Risk |
Pathogenic |
Thyroid hormone metabolism, abnormal 1 |
| RS879255590 |
CLCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
CLCN4-related disorder, CLCN4-related disorder |
| RS879255591 |
CLCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
CLCN4-related disorder, CLCN4-related disorder |
| RS879255592 |
OPA1
|
Health Risk |
Pathogenic |
Optic atrophy with or without deafness, ophthalmoplegia |
| RS879255593 |
OPA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Abortive cerebellar ataxia, Retinal dystrophy |
| RS879255595 |
OPA1
|
Health Risk |
Pathogenic |
Abortive cerebellar ataxia, Autosomal dominant optic atrophy classic form |
| RS879255596 |
NEDD4L
|
Health Risk |
Conflicting classifications of pathogenicity |
Periventricular nodular heterotopia with syndactyly, cleft palate and developmental delay |
| RS879255597 |
NEDD4L
|
Health Risk |
Pathogenic/Likely pathogenic |
Periventricular nodular heterotopia with syndactyly, cleft palate and developmental delay |
| RS879255598 |
NEDD4L
|
Health Risk |
Pathogenic |
Periventricular nodular heterotopia with syndactyly, cleft palate and developmental delay |
| RS879255599 |
NEDD4L
|
Health Risk |
Pathogenic |
Periventricular nodular heterotopia with syndactyly, cleft palate and developmental delay |
| RS879255600 |
ACP5
|
Health Risk |
Pathogenic |
Spondyloenchondrodysplasia with immune dysregulation, Spondyloenchondrodysplasia with immune dysregulation |
| RS879255601 |
TDP2
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive 23 |
| RS879255602 |
NANS
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia, Genevieve type |
| RS879255603 |
SFRP4
|
Health Risk |
Pathogenic |
Pyle metaphyseal dysplasia, Pyle metaphyseal dysplasia |
| RS879255604 |
BGN
|
Health Risk |
Pathogenic |
X-linked spondyloepimetaphyseal dysplasia, X-linked spondyloepimetaphyseal dysplasia |
| RS879255605 |
BGN
|
Health Risk |
Likely pathogenic |
X-linked spondyloepimetaphyseal dysplasia, X-linked spondyloepimetaphyseal dysplasia |
| RS879255606 |
LARS2
|
Health Risk |
Pathogenic |
Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome, Hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome |
| RS879255607 |
PMVK
|
Health Risk |
Pathogenic |
Porokeratosis 1, Mibelli type |
| RS879255608 |
GLIS3
|
Health Risk |
Pathogenic |
Neonatal diabetes mellitus with congenital hypothyroidism, Neonatal diabetes mellitus with congenital hypothyroidism |
| RS879255609 |
GLIS3
|
Health Risk |
Pathogenic |
Neonatal diabetes mellitus with congenital hypothyroidism, Neonatal diabetes mellitus with congenital hypothyroidism |
| RS879255610 |
DOCK6
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 2, Adams-Oliver syndrome 2 |
| RS879255611 |
EDA
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS879255612 |
TOR1AIP2;LOC112577517;TOR1AIP1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Autosomal recessive limb-girdle muscular dystrophy type 2Y |
| RS879255613 |
CTNS
|
Health Risk |
Pathogenic |
Cystinosis, Cystinosis |
| RS879255614 |
CTNS
|
Health Risk |
Pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS879255615 |
CTNS
|
Health Risk |
Pathogenic |
Nephropathic cystinosis, Ocular cystinosis |
| RS879255616 |
CTNS
|
Health Risk |
Likely pathogenic |
Cystinosis, Nephropathic cystinosis |
| RS879255617 |
DGUOK
|
Health Risk |
Pathogenic |
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4 |
| RS879255618 |
SIN3A
|
Health Risk |
Pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |
| RS879255619 |
SIN3A
|
Health Risk |
Pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |
| RS879255620 |
SIN3A
|
Health Risk |
Pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |
| RS879255621 |
SIN3A
|
Health Risk |
Pathogenic |
SIN3A-related intellectual disability syndrome due to a point mutation, SIN3A-related intellectual disability syndrome due to a point mutation |
| RS879255622 |
TRIO
|
Health Risk |
Pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS879255623 |
TRIO
|
Health Risk |
Pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS879255624 |
TRIO
|
Health Risk |
Pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS879255625 |
TRIO
|
Health Risk |
Pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS879255626 |
TRIO
|
Health Risk |
Pathogenic/Likely pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, TRIO-related disorder |
| RS879255627 |
TRIO
|
Health Risk |
Pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome |
| RS879255628 |
TRIO
|
Health Risk |
Pathogenic |
Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome, Intellectual developmental disorder |
| RS879255629 |
EDARADD
|
Health Risk |
Likely pathogenic |
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE |
| RS879255630 |
DNAJC6
|
Health Risk |
Pathogenic |
Parkinson disease 19B, early-onset |
| RS879255631 |
GUF1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 40 |
| RS879255632 |
CDC45
|
Health Risk |
Likely pathogenic |
Meier-Gorlin syndrome 7, Meier-Gorlin syndrome 7 |
| RS879255633 |
CDC45
|
Health Risk |
Likely pathogenic |
Meier-Gorlin syndrome 7, Meier-Gorlin syndrome 7 |
| RS879255634 |
B4GALT7
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome progeroid type, Inborn genetic diseases |
| RS879255635 |
ZBTB20
|
Health Risk |
Likely pathogenic |
— |
| RS879255636 |
PRDM12
|
Health Risk |
Pathogenic |
Congenital insensitivity to pain-hypohidrosis syndrome, Congenital insensitivity to pain-hypohidrosis syndrome |
| RS879255637 |
PRDM12
|
Health Risk |
Pathogenic |
Congenital insensitivity to pain-hypohidrosis syndrome, Congenital insensitivity to pain-hypohidrosis syndrome |
| RS879255638 |
PRDM12
|
Health Risk |
Pathogenic |
Congenital insensitivity to pain-hypohidrosis syndrome, Congenital insensitivity to pain-hypohidrosis syndrome |
| RS879255639 |
FLNC
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, familial restrictive |
| RS879255641 |
GANAB
|
Health Risk |
Pathogenic |
Polycystic kidney disease 3 with or without polycystic liver disease, Polycystic kidney disease 3 with or without polycystic liver disease |
| RS879255642 |
GANAB
|
Health Risk |
Pathogenic |
POLYCYSTIC KIDNEY DISEASE 3 WITHOUT POLYCYSTIC LIVER DISEASE, POLYCYSTIC KIDNEY DISEASE 3 WITHOUT POLYCYSTIC LIVER DISEASE |
| RS879255643 |
GANAB
|
Health Risk |
Likely pathogenic |
POLYCYSTIC KIDNEY DISEASE 3 WITH POLYCYSTIC LIVER DISEASE, Polycystic kidney disease 3 with or without polycystic liver disease |
| RS879255644 |
NR1H4
|
Health Risk |
Pathogenic |
Cholestasis, progressive familial intrahepatic |
| RS879255645 |
VAC14
|
Health Risk |
Pathogenic |
Striatonigral degeneration, childhood-onset |
| RS879255646 |
AP3D1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 10, Hermansky-Pudlak syndrome 10 |
| RS879255647 |
NAXE
|
Health Risk |
Pathogenic |
Encephalopathy, progressive |
| RS879255648 |
SEC61A1
|
Health Risk |
Pathogenic |
Hyperuricemic nephropathy, familial juvenile type 4 |
| RS879255649 |
CCDC88A
|
Health Risk |
Pathogenic |
PEHO-like syndrome, PEHO-like syndrome |
| RS879255651 |
MME
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia 43, Spinocerebellar ataxia 43 |
| RS879255652 |
SCN8A
|
Health Risk |
Pathogenic |
Seizures, benign familial infantile |
| RS879255653 |
CWF19L1
|
Health Risk |
Pathogenic |
Autosomal recessive spinocerebellar ataxia 17, Autosomal recessive spinocerebellar ataxia 17 |
| RS879255654 |
CWF19L1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 17, Autosomal recessive spinocerebellar ataxia 17 |
| RS879255655 |
DYNC2LI1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 15 with polydactyly, Asphyxiating thoracic dystrophy 1 |
| RS879255656 |
DYNC2LI1
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 15 with polydactyly, Asphyxiating thoracic dystrophy 1 |
| RS879255657 |
PNPT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined oxidative phosphorylation defect type 13, Combined oxidative phosphorylation defect type 13 |
| RS879255658 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS879255660 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome 1 |
| RS879255661 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS879255662 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome 1 |
| RS879255663 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS879255664 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS879255665 |
FLCN
|
Health Risk |
Conflicting classifications of pathogenicity |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS879255666 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS879255667 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS879255668 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |
| RS879255669 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS879255670 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS879255672 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS879255673 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Birt-Hogg-Dube syndrome |
| RS879255675 |
FLCN
|
Health Risk |
Pathogenic |
Birt-Hogg-Dube syndrome, Hereditary cancer-predisposing syndrome |